Declare That Atropine Sulfate Injection, USP 1.0 mg/mL, 1 mL fill in a 2 mL Glass Vial is Suitable for Submission as an Abbreviated New Drug Application (ANDA); CLOSED
🏛 Food and Drug Administration (FDA)FDA-2012-P-0986
Documents
3
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
OtherAug 4, 2026
Updated Withdrawal Response Letter from FDA CDER to Luitpold Pharmaceuticals, Inc.No comment period
- Other· Mar 8, 2018Closed on Sep 4, 2018
- Other· Sep 26, 2012No comment period